Neuropsychological Sequelae and Long COVID-19 Fatigue (PostCoV2Psy)
Neuropsychological Sequelae as a Risk Factor for Long COVID-19 Fatigue
Sponsor: Centro Hospitalar Universitario do Algarve
A observational or N/A phase clinical study on Anxiety Depression and COVID-19, this trial is ongoing. The trial is conducted by Centro Hospitalar Universitario do Algarve and has accumulated 9 data snapshots since 2022. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Apr 2025 — Sep 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Apr 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Dec 2022 — Apr 2023 [monthly]
Recruiting
-
Sep 2022 — Dec 2022 [monthly]
Recruiting
-
Jun 2022 — Sep 2022 [monthly]
Recruiting
-
May 2022 — Jun 2022 [monthly]
Recruiting
First recorded
Apr 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centro Hospitalar Universitario do Algarve
- Universidade do Algarve
- Universidade do Porto
For direct contact, visit the study record on ClinicalTrials.gov .